Facultad de Medicina (FM)
Centro académico
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Icahn School of Medicine at Mount Sinai (128)
2024
-
A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey
European Journal of Surgical Oncology, Vol. 50, Núm. 10
-
Correction to: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review (Blood Cancer Journal, (2024), 14, 1, (24), 10.1038/s41408-023-00966-9)
Blood Cancer Journal
-
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Blood Cancer Journal, Vol. 14, Núm. 1
-
Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP
Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 559-564
-
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100
-
Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery
Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490
-
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
Cell Reports, Vol. 43, Núm. 3
-
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Nature Medicine, Vol. 30, Núm. 7, pp. 2020-2029
-
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4
-
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma
Gut
-
The tip of the iceberg: a plethora of lung nodules in the general population
The European respiratory journal
2023
-
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)
Radiology, Vol. 309, Núm. 2, pp. e231988
-
Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
JCI Insight, Vol. 8, Núm. 2
-
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
Blood cancer journal
-
Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide
The Lancet Oncology, Vol. 24, Núm. 12, pp. e472-e518
-
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma
Future Oncology, Vol. 19, Núm. 27, pp. 1823-1840
-
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
ESMO Open, Vol. 8, Núm. 3
2022
-
Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
Cancers, Vol. 14, Núm. 1
-
Cancer vaccines: the next immunotherapy frontier
Nature Cancer, Vol. 3, Núm. 8, pp. 911-926
-
Clinical and technical outcomes of patients undergoing endoscopic ultrasound-guided gastroenterostomy using 20-mm vs15-mm lumen-apposing metal stents
Endoscopy, Vol. 54, Núm. 7, pp. 680-687